Application 022288
- Type
- NDA
- Sponsor
- BAUSCH AND LOMB INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | BEPREVE | BEPOTASTINE BESILATE | SOLUTION/DROPS;OPHTHALMIC | 1.5% | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N022288-001 | BEPREVE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS | 2009-09-08 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N022288-001 | AT |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N022288-001 | BEPREVE | 1.5% | SOLUTION/DROPS / OPHTHALMIC | AT | RLD, RS | 2009-09-08 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | N022288-001 | AT | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Bepotastine Besilate | BEPOTASTINE BESILATE | Bausch & Lomb Americas Inc. | 70430ab5-cd0a-451e-acab-347a2f981898 | 2024-08-20 | Warnings, Adverse reactions | 022288 NDA022288 82260-630 |
| Bepreve | BEPOTASTINE BESILATE | Bausch & Lomb Incorporated | 68bbf6a0-c4b5-47c1-8a1c-08220fbdbce6 | 2022-08-31 | Warnings, Adverse reactions | 022288 NDA022288 24208-629 |
| Bepotastine Besilate | BEPOTASTINE BESILATE | Bausch & Lomb Incorporated | 995f4fe0-d861-4137-8090-a8ffc71c46f4 | 2020-12-31 | Warnings, Adverse reactions | 022288 NDA022288 24208-630 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 24208-629 | Bepreve | bepotastine besilate | Bausch & Lomb Incorporated | NDA | Current |
| 24208-629 | Bepreve | bepotastine besilate | Bausch & Lomb Incorporated | NDA | Current |
| 24208-629 | Bepreve | bepotastine besilate | Bausch & Lomb Incorporated | NDA | Current |
| 24208-629 | Bepreve | bepotastine besilate | Bausch & Lomb Incorporated | NDA | Current |
| 24208-629 | Bepreve | bepotastine besilate | Bausch & Lomb Incorporated | NDA | Current |
| 24208-630 | Bepotastine Besilate | bepotastine besilate | Bausch & Lomb Incorporated | NDA AUTHORIZED GENERIC | Current |
| 82260-630 | Bepotastine Besilate | bepotastine besilate | Bausch & Lomb Americas Inc. | NDA AUTHORIZED GENERIC | Current |
| 82260-630 | Bepotastine Besilate | bepotastine besilate | Bausch & Lomb Americas Inc. | NDA AUTHORIZED GENERIC | Current |